@Article{ecn.2026.083162,
AUTHOR = {Hitoshi Uga, Takahiro Okazawa, Yoshiaki Miyamoto, Takehiro Hasegawa, Jun Saegusa, Akio Morinobu, Shunichi Kumagai, Hirokazu Kurata},
TITLE = {Distinct serum chemokine signatures differentiate rheumatoid arthritis from non-rheumatoid arthritides},
JOURNAL = {European Cytokine Network},
VOLUME = {},
YEAR = {},
NUMBER = {},
PAGES = {{pages}},
URL = {http://www.techscience.com/ECN/online/detail/27509},
ISSN = {1952-4005},
ABSTRACT = { <b>Background:</b> Early and accurate differential diagnosis of rheumatoid arthritis (RA) remains challenging, particularly in patients with seronegative or non-specific inflammatory arthritides. Because cytokines and chemokines play central roles in immune activation and leukocyte trafficking, we investigated whether serum cytokine and chemokine profiles could discriminate RA from non-rheumatoid arthritides (NRA) and healthy controls (HCs). <b>Methods:</b> One hundred and fifty-seven RA patients (104 anti-cyclic citrullinated peptide antibody (ACPA)-positive and 53 ACPA-negative patients), 33 NRA patients and 86 HCs were included. Fourteen cytokines and twelve chemokines were measured in the sera of the above three cohorts, using high-sensitivity chemi-luminescence immunoassay. Results were analyzed by non-parametric Mann-Whitney U-test and multiple logistic regression analysis. <b>Results:</b> Among the parameters, eight chemokines (CCL3, 4, 11, 20, 27, CXCL9, 10 and 13) were significantly upregulated in RA patients as compared with NRA patients and HCs (Mann-Whitney U-test: <i>p</i> &lt; 0.01). Multiple logistic regression analysis revealed that the combination of four chemokines (CCL3, 11, 27 and CXCL13) can effectively discriminate RA from NRA patients and HCs (Area Under the Curve (AUC) = 0.92), as well as ACPA-negative RA from NRA patients (AUC = 0.73). <b>Conclusions:</b> A serum four-chemokine signature consisting of CCL3, CCL11, CCL27, and CXCL13 discriminated RA, including ACPA-negative RA, from non-rheumatoid arthritides and healthy controls. These findings suggest that serum chemokine profiling may provide adjunctive diagnostic information for the differential diagnosis of RA.},
DOI = {10.32604/ecn.2026.083162}
}